Is PRDO a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Perdoceo Education Corporation (PRDO) rests on St. Augustine is the segment carrying the growth: USAHS revenue rose ~9.8% to ~$41.7 million in the September 2026 quarter and operating income rose to ~$4.6 million from roughly break-even a year earlier; year to date it has earned ~$14.6 million against a ~$2.0 million loss in the same period of 2025. The bear case rests on the dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

PRDO key stats

At $27.47 on November 20, 2026, Perdoceo Education Corporation (PRDO) has a market cap of $1.7B, a P/E of 9.6 on trailing earnings (8.3 on forward earnings) and a dividend yield of 2.48%.

Market cap
$1.7B
P/E (trailing)
9.6
P/E (forward)
8.3
EPS (trailing 12 months)
$2.86
Price to book
1.6
Dividend yield
2.48%
Beta
0.75

Market cap, P/E and yield are measured at the $27.47 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Perdoceo Education Corporation (PRDO)?

The last two weeks for Perdoceo Education Corporation, as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • PRDO closed at $27.47 on November 20, 2026, down 5.2% over the past five trading days (from $28.99).

Perdoceo Education Corporation filed no current, quarterly or annual report with the SEC in the last two weeks.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Perdoceo Education Corporation (Nasdaq: PRDO) is the Schaumburg, Illinois company that used to trade as Career Education Corporation; it took the Perdoceo name in December 2019 after shedding its campus-heavy culinary and art-school businesses. What remains is three accredited postsecondary institutions. Colorado Technical University is the largest, at ~31,870 students as of September 30, 2026 (down ~0.5%) and about two thirds of total enrolment, with roughly 98% of those students fully online. The American InterContinental University System adds ~10,830 students, up ~7.5%, also almost entirely online. The third piece, the University of St. Augustine for Health Sciences, is the odd one out and the interesting one: a campus-based graduate school in physical therapy, occupational therapy, speech language therapy and nursing, ~4,560 students, up ~3.2%, with revenue growing near 10%. Total enrolment across all three was ~47,260, up ~1.6% year over year. The investment picture is almost entirely about the gap between that slow enrolment line and the earnings line. Revenue for the quarter ended September 30, 2026 rose ~1.9% to ~$215.9 million, but diluted EPS rose ~16.7% to ~$0.70 (adjusted ~$0.77, up ~18.5% and ahead of the ~$0.74 consensus), because operating income grew ~8.1%, amortisation is rolling off and the share count keeps shrinking through buybacks. Year to date, diluted EPS is ~$2.31 against ~$1.87 a year earlier. Perdoceo carries ~$776.9 million in cash, restricted cash and short-term investments against no conventional debt (Yahoo Finance lists ~$110 million of debt-like obligations), which is roughly ~45% of the ~$1.72 billion market capitalisation at ~$27.77 on November 20, 2026. The market has priced this at ~9.7x trailing earnings (~8.4x forward) and about ~4.3x enterprise value to trailing EBITDA, a discount that has persisted for years and that reflects a real structural fact: for the year ended December 31, 2025 the company took in approximately ~$615 million of Title IV federal student aid cash against ~$846.1 million of revenue, so most of the business runs on money Congress appropriates. The story added a new chapter on September 14, 2026, when Perdoceo signed a definitive agreement to acquire South University: ~$130 million to ~$150 million in cash at closing depending on balance-sheet adjustments, ~$18 million of deferred consideration over 24 months, and up to ~$56 million of earn-out payments tied to 2027-2029 EBITDA. South, founded in 1899, has 11 campuses in the southern US plus online programmes, ~10,500 students as of December, and reported fiscal 2025 revenue of ~$291 million and adjusted operating income of ~$34 million, with licensure-based programmes in physician assistant studies, anesthesiology, nursing and pharmacy. It is currently a nonprofit and would become for-profit; closing needs regulatory and accreditor approval, management said in November it is on track to close as early as April 2027 and expects the deal to add to adjusted operating income from 2027, and the agreement can be terminated if it has not closed by July 9, 2027. The shares closed at ~$27.77 on November 20, down ~4.6% year to date and ~4.8% over twelve months, after an ~18% fall over the prior month that put them near the bottom of a ~$26.24 to ~$38.50 52-week range.

The bull case for PRDO

1. St. Augustine is the segment carrying the growth

USAHS revenue rose ~9.8% to ~$41.7 million in the September 2026 quarter and operating income rose to ~$4.6 million from roughly break-even a year earlier; year to date it has earned ~$14.6 million against a ~$2.0 million loss in the same period of 2025. Enrolment there is up ~3.2% while CTU is down ~0.5%, and AIUS has turned to growth of ~7.5%. Graduate health sciences programmes carry higher tuition and stickier demand than online business degrees, so the mix shift is doing more for consolidated margin than the headline revenue growth suggests. The South University deal would add a second, larger health sciences school with ~$291 million of revenue, roughly a third more revenue for the group, so the health sciences mix is set to become the main story if it closes.

2. Earnings growth is being manufactured below the revenue line

Year to date revenue grew ~2.6% while operating income grew ~12.3% and diluted EPS grew from ~$1.87 to ~$2.31. In the first half, depreciation and amortisation fell to ~$18.7 million from ~$22.0 million as acquired intangibles amortise away, weighted average diluted shares fell from ~66.7 million to ~63.5 million, and the effective tax rate dropped to ~20.6% from ~24.9% on discrete items including the resolution of a state tax matter. The first two are durable; the third is not. Buybacks continued in the third quarter, with ~0.6 million shares repurchased for ~$19.9 million.

3. The balance sheet is nearly half the market cap and is being returned

Cash, restricted cash and short-term investments reached ~$776.9 million at September 30, 2026, up from ~$643.5 million at year end, against ~$57.2 million of failed sale-leaseback financing and modest finance leases. The board raised the quarterly dividend ~13.3% to ~$0.17 in August 2026 and declared another ~$0.17 on November 5, payable December 11 to holders of record on November 27; ~$65.1 million remains on the repurchase authorisation. Management also describes acquisitions as an active use of that cash, and in September 2026 it committed ~$130 million to ~$150 million of it at closing, plus deferred payments and up to ~$56 million of earn-outs, to South University, so the pile is not purely a valuation floor.

4. The 2026 outlook implies a step up, not a plateau

For the full year the company now guides to operating income of ~$221.0 million to ~$224.0 million against ~$196.0 million in 2025, and diluted EPS of ~$2.93 to ~$2.97 (adjusted ~$3.15 to ~$3.19) against ~$2.42. That is roughly ~9.4x the diluted midpoint at the ~$27.77 share price of November 20, 2026, or nearer ~8.8x on the adjusted figure; analyst consensus sits at ~$3.17 for 2026 and ~$3.30 for 2027. Fourth-quarter guidance is diluted EPS of ~$0.63 to ~$0.67. The outlook assumes federal student aid availability holds, no significant operating impact from the company's settlement with the Federal Trade Commission, and legal fees in line with expectations.

The bear case for PRDO

The dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions. All three institutions were preliminarily in compliance with the 90/10 rule for 2025 and improved versus the prior year, but the calculation methodology is unsettled and the penalty for two consecutive years above the threshold is loss of Title IV eligibility for at least two fiscal years. The elimination of Grad PLUS for new borrowers from July 1, 2026, with new caps on graduate Direct Unsubsidized borrowing, lands squarely on USAHS, the one segment carrying the growth, and the company's assumption that displaced students find private lending is untested. Two False Claims Act qui tam suits brought by former Colorado Technical University employees are live in the District of Colorado, both seeking treble damages, with the Department of Justice having declined to intervene in each; the company has recognised no liability and cannot estimate a range, and higher legal fees again held back CTU segment operating income in the third quarter. Finally, the core online universities are barely growing, marketing is lead-driven, and Perdoceo itself flags increased use of AI assistants in place of search engines as a factor that could disrupt how it reaches prospective students. The South University acquisition adds integration and approval risk: it needs regulatory and accreditor sign-off, South has changed control four times in under a decade, and converting it from nonprofit to for-profit status brings it under the 90/10 rule and the same Title IV scrutiny as the rest of the group. The stock's ~18% drop in the month to November 20, 2026, after a quarter that beat estimates, shows how quickly sentiment on the sector can swing.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding PRDO already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on PRDO

Too few analysts publish on PRDO for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The PRDO forecast page covers what coverage does exist.

How is PRDO valued?

Market cap, P/E and dividend yield at today's price are in the PRDO key stats above. The business figures below come from Perdoceo Education Corporation's reported results as of November 2026 and change when it next reports.

  • Revenue (TTM): ~$863M, up ~1.9% year over year in Q3 2026
  • Latest quarter (Q3 2026): Adjusted EPS ~$0.77 vs ~$0.74 estimate; revenue ~$215.9M
  • Cash and short-term investments: ~$777M against ~$110M of debt-like obligations, roughly 45% of market cap
  • FY2026 company outlook: diluted EPS of ~$2.93 to ~$2.97, adjusted ~$3.15 to ~$3.19; consensus ~$3.17
  • Dividend: ~$0.17 per quarter (~$0.68 a year), ~2.4% yield, ~22% payout
  • Pending acquisition: South University, ~$130M-150M cash at close, ~$18M deferred, up to ~$56M earn-out; close expected as early as April 2027

As of November 2026: The trailing multiple looks unusually low until the cash is stripped out, at which point enterprise value is about 4.3 times trailing EBITDA. That is the market applying a persistent discount to Title IV dependence and litigation overhang, and the fall to ~$27.77 by November 20, 2026 widened it. Two things to check against the filings: part of 2026 EPS growth came from a lower effective tax rate in the first half (~20.6% versus ~24.9%), and the South University purchase would reduce the cash cushion by roughly a fifth when it closes.

How do you decide if PRDO is a buy?

Whether PRDO is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold PRDO indirectly through an index or sector ETF before adding more.

What would change your mind on PRDO

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: St. Augustine is the segment carrying the growth stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: the dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the PRDO stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about PRDO against your real portfolio and see your actual exposure before deciding.

Your questions about Perdoceo Education Corporation

Ask Walnut's AI anything about PRDO and see how it fits what you own.

FAQ

Is PRDO a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on St. Augustine is the segment carrying the growth, with revenue (ttm) at ~$863M, up ~1.9% year over year in Q3 2026. The bear case rests on the dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell PRDO?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. Walnut is not an investment adviser.

What is the bull case for PRDO?

+

St. Augustine is the segment carrying the growth. USAHS revenue rose ~9.8% to ~$41.7 million in the September 2026 quarter and operating income rose to ~$4.6 million from roughly break-even a year earlier; year to date it has earned ~$14.6 million against a ~$2.0 million loss in the same period of 2025.

What is the bear case for PRDO?

+

The dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions. All three institutions were preliminarily in compliance with the 90/10 rule for 2025 and improved versus the prior year, but the calculation methodology is unsettled and the penalty for two consecutive years above the threshold is loss of Title IV eligibility for at least two fiscal years. The elimination of Grad PLUS for new borrowers from July 1, 2026, with new caps on graduate Direct Unsubsidized borrowing, lands squarely on USAHS, the one segment carrying the growth, and the company's assumption that displaced students find private lending is untested. Two False Claims Act qui tam suits brought by former Colorado Technical University employees are live in the District of Colorado, both seeking treble damages, with the Department of Justice having declined to intervene in each; the company has recognised no liability and cannot estimate a range, and higher legal fees again held back CTU segment operating income in the third quarter. Finally, the core online universities are barely growing, marketing is lead-driven, and Perdoceo itself flags increased use of AI assistants in place of search engines as a factor that could disrupt how it reaches prospective students. The South University acquisition adds integration and approval risk: it needs regulatory and accreditor sign-off, South has changed control four times in under a decade, and converting it from nonprofit to for-profit status brings it under the 90/10 rule and the same Title IV scrutiny as the rest of the group. The stock's ~18% drop in the month to November 20, 2026, after a quarter that beat estimates, shows how quickly sentiment on the sector can swing.

What does Perdoceo Education Corporation do?

+

Perdoceo Education Corporation runs three accredited postsecondary institutions and traded as Career Education Corporation until December 2019.

What would have to change for PRDO to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (St. Augustine is the segment carrying the growth) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the dominant risk is regulatory concentration more than competition: approximately ~$615 million of Title IV cash receipts in 2025 against ~$846.1 million of revenue means a change in federal aid rules, eligibility, or appropriations flows almost directly into the P&L, and management lists a government shutdown or Department of Education restructuring among its own guidance assumptions) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Perdoceo Education Corporation actually do?

+

It owns and operates three accredited postsecondary institutions in the United States: Colorado Technical University, the American InterContinental University System and the University of St. Augustine for Health Sciences. The first two are almost entirely online and serve working adults; the third is a campus-based graduate school for physical therapy, occupational therapy, speech language therapy and nursing. Roughly ~47,260 students were enrolled at September 30, 2026.

Is PRDO the same company as Career Education Corporation?

+

Yes. The SEC registrant is CIK 0001046568, which filed as Career Education Corp until the name change was recorded on December 18, 2019. The ticker did not change hands to a different business. The company that trades as PRDO today is the same legal entity, minus the culinary and art institute campuses it exited before the rename.

How dependent is Perdoceo on federal student aid?

+

Heavily. For the year ended December 31, 2025 the company disclosed Title IV Program cash receipts of approximately ~$615 million against total revenue of ~$846.1 million. All three institutions were preliminarily in compliance with the 90/10 rule for 2025 and improved versus 2024, but the rule remains the sector's binding constraint: two consecutive years above 90% federal revenue costs an institution Title IV eligibility for at least two fiscal years.

Walnut is informational, not investment advice, and gives no verdict on PRDO. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks